NEW
YORK, Jan. 6, 2025 /PRNewswire/ -- Baird Medical
(NASDAQ: BDMD), a global leader in minimally invasive microwave
ablation (MWA) technology, successfully sponsored and participated
in the 4th Sichuan Medical Association Thyroid Disease Academic
Conference, held in Sichuan,
China.
The highly regarded conference gathered top thyroid specialists
and healthcare professionals to promote best practices in thyroid
disease diagnosis and treatment. Baird Medical's sponsorship
underscored its commitment to advancing medical innovation and
fostering academic collaboration in China's growing healthcare sector.
During the event, Baird Medical presented its state-of-the-art
MWA technology for thyroid nodules. The innovative solution,
designed to deliver larger ablation zones and shorter treatment
times, attracted significant attention for its potential to improve
patient outcomes and set new standards for minimally invasive care.
The company also engaged in high-level discussions with medical
leaders, further solidifying its position as a key player in the
global healthcare market.
"Our participation in this prominent conference reflected
Baird Medical's commitment to supporting advancements in thyroid
disease treatment," said Haimei Wu, Chairwoman of Baird
Medical. "By presenting our latest MWA technology, we
contributed to the ongoing dialogue on improving treatment options
and patient outcomes. We remain dedicated to collaborating with
medical professionals to promote innovation and enhance care
standards globally."
About Baird Medical
Baird Medical is a leading
provider of minimally invasive microwave ablation (MWA) technology,
offering advanced treatment solutions for conditions such as
thyroid nodules, breast disease, uterine fibroids, and liver
cancer. A publicly traded company on NASDAQ, Baird Medical is
dedicated to enhancing patient care through precision, efficiency,
and safety in its innovative medical devices. For more information,
please visit https://bairdmed.com/
Forward-Looking Statements
This press release contains
forward-looking statements within the meaning of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements are statements that are not historical facts and
generally relate to future events or Baird Medical's future
financial or operational performance. In some cases, you can
identify forward-looking statements by terminology such as "may,"
"might," "will," "should," "expect," "intend," "plan,"
"anticipate," "believe," "estimate," "predict," "potential,"
"continue," or the negative of these terms or other similar
expressions.
These forward-looking statements are subject to risks,
uncertainties, and assumptions that could cause actual results or
outcomes to differ materially from those expressed or implied.
These statements are based on estimates and assumptions that, while
considered reasonable by Baird Medical and its management, are
inherently uncertain. Risks and uncertainties may emerge over time,
and it is not possible to anticipate all potential factors that
could affect Baird Medical's business and financial
performance.
Factors that could cause actual results to differ materially
include, but are not limited to: (1) the risk that Baird Medical
may not achieve its expansion goals in the United States, China, or other markets; (2) changes in
economic, regulatory, or market conditions that impact Baird
Medical's operations; (3) the ability to realize anticipated
benefits from ongoing business initiatives or strategic
transactions; (4) regulatory developments and compliance with
applicable laws; (5) risks related to the development,
commercialization, and market acceptance of Baird Medical's
products; and (6) other risks and uncertainties detailed in Baird
Medical's filings with the SEC.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they
are made. Baird Medical undertakes no obligation to update or
revise forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law. All forward-looking statements in this press release are
qualified in their entirety by this cautionary statement.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsored-and-showcased-advanced-microwave-ablation-mwa-technology-at-the-sichuan-medical-association-thyroid-disease-conference-302342737.html
SOURCE BDMD